Crescent Biopharma CBIO
NASDAQ CBIO
$16.66 +0.43 (+2.65%)
As of: Aug 21, 2026 · 12:13 PM EDT

Crescent Biopharma (CBIO) Operating Margin Growth (3y) (2016)

Crescent Biopharma (CBIO) Operating Margin Growth (3y) (2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.77 Bn 131.91 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.74 Bn 78.75 Bn 3.93 Bn -204.00
3 Argenx Se 65.36 Bn 60.17 Bn 1.37 Bn -537.00
4 Moderna 59.60 Bn 54.47 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.13 Bn 9.73 Bn 668.28 Mn -11,254.00
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.31 Bn 26.47 Bn - -2,649.00
10 Crescent Biopharma 1.07 Bn 903.34 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 -3.56 Mn